MedTrace Logo

Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care

NCT02950649 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2022-04-21

No results posted yet for this study

Summary

This project is designed to assess the impact of pre-operative use of non-invasive hemodynamic monitoring technologies on improving peri-operative and post-operative care of moderate to high-risk surgical patients with poor functional status by improving the detection of reduced cardiovascular function.

Conditions

  • Hemodynamic Monitoring

Interventions

DEVICE

invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences

Experimental: Hemodynamic Monitored Guided Assesment This group will have the non-invasive hemodynamic monitoring device placed and its data will help guide (intervention) patient's management decisions (experimental).

DEVICE

No Hemodynamic Monitored Guided Assesment

Arm: Active Comparator: No Hemodynamic Monitored Guided Assesment This group will have the non-invasive hemodynamic monitoring device placed but its data will NOT be factored for intervention of the patient's management decisions.

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Davinder Ramsingh, MD · Loma Linda University Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-17
Primary Completion
2021-06-14
Completion
2021-06-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02950649 on ClinicalTrials.gov